Publications
157
Citations
10,507
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Michelle Rainka's work focuses on clinical neurology and pharmacy practice, particularly medication management for neurological and psychiatric conditions such as Parkinson's disease, multiple sclerosis, dementia, and stroke. Much of the research involves clinical pharmacist-led interventions, drug therapy outcomes (including medical cannabis, antiplatelets, and antipsychotics), and more recently touches on computational approaches like deep learning for brain imaging and disease severity prediction. The work is largely applied and clinical, often produced in collaboration with multidisciplinary healthcare teams.
Publication output has been fairly steady over the last decade, fluctuating between about 9 and 15 papers per year, with a slight decline in the most recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Interpretable deep learning reveals spatiotemporal MRI features of brain aging that align with neurodegeneration
GeroScience · 2026
- Mutual learning for joint disease detection and severity prediction reveals multimodal pathogenesis for neurodegenerative disorders
Bioinformatics · 2025
- DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
JCO Precision Oncology · 2024
- Medical Cannabis in the Treatment of Parkinson’s Disease
Clinical Neuropharmacology · 2023
- Impact of Medication Optimization and Recommendations by Clinical Pharmacists Embedded in a Memory Disorder Clinic (P3-7.005)
Neurology · 2023
- Parkinson's Disease Psychosis Questionnaire
PsycTESTS Dataset · 2022
- Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review of a Neurology Outpatient Population
International Journal of MS Care · 2022
- Impact of medication optimization and recommendations by clinical pharmacists embedded in a memory disorder clinic
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2022
- Evaluating outcomes of a clinical pharmacist medication management program in a multidisciplinary practice for outpatient buprenorphine treatment of opioid use disorder
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2021
- Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Effective?
Journal of Pharmacy Practice · 2021
- Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics
Journal of Clinical Psychopharmacology · 2020
- Evaluating rates of reporting symptoms of Parkinson’s disease psychosis: provider versus targeted questionnaire
International Journal of Neuroscience · 2020
- L-Methylfolate Calcium Supplementation in Adolescents and Children: A Retrospective Analysis (4226)
Neurology · 2020
- Pharmacist intervention and <scp>anti‐platelet</scp> medication monitoring in patients following stroke and transient ischemic attack
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2020
- Risk of Recurrent Stroke or Transient Ischemic Attack due to Abrupt Discontinuation of Aspirin: A Case Series (5135)
Neurology · 2020
- Scientific Reports×26
- Neurology×24
- Nature Communications×15
- GeroScience×8
- Proceedings of the National Academy of Sciences×7
- Brandy R. Matthews
Medicine · Indiana University
- Anne M. Fagan
Medicine · Indiana University
- Andrew J. Saykin
Medicine · Indiana University
- Ann Marie Hake
Medicine · Indiana University
- Daniel Silverman
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile